Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

What Doctors Don't Tell You

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!
June 2020 (Vol. 5 Issue 4)

Pharmaceutical profits continue to soar
About the author: 
Bryan Hubbard

Pharmaceutical profits continue to soar image

Pharmaceutical sales keep going up and up, and the industry is set to hit $1.18 trillion in global sales by 2024

Overprescribing and addiction to the powerful opioid painkillers have been headline news for several years—and you'd be forgiven for assuming the drugs are fueling the annual growth of prescription drug sales around the world.


But they don't even come close. Pharmaceutical sales are growing by an average of 6 percent a year and are anticipated to hit $1.18 trillion globally by 2024—but opioids play a minor part in that growth.


In the 10 years from 2008 to 2018, opioid sales have increased by around 20 percent—but that's dwarfed by a range of other drugs. Over the same period, the epilepsy and anxiety drug Lyrica (pregabalin) has seen sales rocket by 660 percent, and the anticonvulsant Neurontin (gabapentin) by 319 percent. Antidepressants have also shown strong growth, with a 97 percent rise in annual sales.


Growth is one thing; revenue generated by sales is another, and way out in the lead are the anticancer drugs, whose anticipated revenues by 2024 will reach $236.6 billion worldwide. That's more than the next six drug categories combined.


In 2018, the drugs generated sales of $123.8 billion, and industry experts are expecting those sales to rise by 11 percent as up to one in two of us are diagnosed with cancer.1


Diabetes drugs are also expected to continue their growth—aided by our diet of fast food—with sales expected to reach $57.6 billion globally by 2024, while vaccine sales are forecast to hit $44.8 billion, showing a growth spurt of 6.6 percent, thanks to the various health scares about measles and the rest.


With 50 percent of adults in America now taking at least one prescription drug every month, and one in four taking three or more drugs, the take-home message is simple enough: don't sell your shares in Big Pharma just yet.

Looking back: drug best-sellers
Increase in sales, 2008 to 2018
(Source: NHS UK)

Read all about it - but only in WDDTY

We are one of the only voices out there to give you in-depth, independent and proven information about holistic ways to control your health. Get direct access to all this information every month, via subscription, delivered to your door, anywhere in the world—as thousands of others do.

References

References
1 EvaluatePharma World Preview 2019

You may also be interested in...

Support WDDTY

Help support us to hold the drugs companies, governments and the medical establishment accountable for what they do.

Advertisements

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions..

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

© 2010 - 2019 WDDTY Publishing Ltd.
All Rights Reserved